CNR Institutional Research Information System

DE FALCO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 789
NA - Nord America 565
EU - Europa 185
SA - Sud America 149
AF - Africa 17
OC - Oceania 1
Totale 1.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 534
SG - Singapore 342
CN - Cina 175
BR - Brasile 118
VN - Vietnam 87
HK - Hong Kong 83
IT - Italia 50
FR - Francia 41
JP - Giappone 25
NL - Olanda 20
KR - Corea 16
AR - Argentina 15
BD - Bangladesh 13
DE - Germania 13
MX - Messico 13
GB - Regno Unito 12
FI - Finlandia 11
CA - Canada 10
IN - India 9
EC - Ecuador 7
ID - Indonesia 7
UA - Ucraina 7
IQ - Iraq 6
ZA - Sudafrica 6
AT - Austria 5
SE - Svezia 5
IE - Irlanda 4
TR - Turchia 4
CO - Colombia 3
DZ - Algeria 3
ES - Italia 3
HN - Honduras 3
IL - Israele 3
NG - Nigeria 3
RU - Federazione Russa 3
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
HU - Ungheria 2
PK - Pakistan 2
PY - Paraguay 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 1.706
Salva come PNG Salva come JPEG
Città #
Santa Clara 201
Singapore 180
Hong Kong 82
Beijing 56
Hefei 40
Lauterbourg 36
Ashburn 35
San Jose 34
Ho Chi Minh City 33
Los Angeles 32
Tokyo 20
Hanoi 19
Seoul 16
Helsinki 10
Marigliano 10
São Paulo 10
Buffalo 9
New York 9
Johannesburg 6
Brooklyn 5
Denver 5
London 5
Stockholm 5
Washington 5
Avellino 4
Baghdad 4
Curitiba 4
Dallas 4
Florence 4
Haiphong 4
Lecce 4
Naples 4
Nuremberg 4
Orem 4
Rome 4
The Bronx 4
Acalanes Ridge 3
Boardman 3
Chennai 3
Chicago 3
Dhaka 3
Falkenstein 3
Mexico City 3
Milan 3
Querétaro 3
Rio de Janeiro 3
San Francisco 3
Seattle 3
Vienna 3
Amsterdam 2
Araranguá 2
Bariri 2
Bengaluru 2
Brescia 2
Buenos Aires 2
Campinas 2
Dublin 2
Eagleville 2
Gainesville 2
Goiânia 2
Guayaquil 2
Houston 2
La Crosse 2
Lagos 2
Las Vegas 2
Leesburg 2
Lithia Springs 2
Lomas de Zamora 2
Manchester 2
Marília 2
Miami 2
Milwaukee 2
Minamishinagawa 2
Montreal 2
Newark 2
Nicosia 2
Ninh Bình 2
Niterói 2
Osaka 2
Osasco 2
Phoenix 2
Phủ Lý 2
Piscataway 2
Queens 2
Quito 2
Quảng Ninh 2
Salvador 2
San José 2
Serrinha 2
Shanghai 2
Shenzhen 2
Spotorno 2
Tashkent 2
The Dalles 2
Toronto 2
Trenton 2
Uberlândia 2
Vinh 2
Abuja 1
Addis Ababa 1
Totale 1.050
Salva come PNG Salva come JPEG
Nome #
N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma 75
The b-catenin Axis Integrates Multiple Signals Downstream From RET/PTC and Leads to Cell Proliferation. 71
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics 62
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure 59
Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer 59
The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19) 58
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells 57
Targeted Cancer Therapy and Mechanisms of Resistance 56
Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: Identification of gain-of-function mutations in the RET proto-oncogene 53
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer. 53
p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors 51
Effects of combined administration of rapamycin, tolvaptan and AEZ-131 on progression of polycystic disease in PCK rats. 50
CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. 50
A novel pathway of cell growth regulation mediated by a PLA2alpha-derived phosphoinositide metabolite 48
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology 47
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer 47
Calcium/calmodulin-dependent protein kinase II and its endogenous inhibitor ? in medullary thyroid cancer. 46
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. 45
XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt. 44
Calcium/calmodulin-dependent protein kinase II and ITS endogenous inhibitor a in medullary thyroid cancer 43
Cytosolic phospholipase A2 alpha regulates cell growth in RET/PTC-transformed thyroid cells 43
BRAF is a therapeutic target in aggressive thyroid carcinoma. 41
The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC 40
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. 40
Glioblastoma: Overview of Proteomic Investigations and Biobank Approaches for the Development of a Multidisciplinary Translational Network 39
XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. 39
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells 38
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. 37
Targeting RET Kinase in Thyroid Cancer 36
Mitochondrial Localization and Regulation of BRAF(V600E) in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAF(V600E) 35
The β-Catenin axis integrates multiple signals downstream from RET/Papillary thyroid carcinoma leading to cell proliferation 34
Biochemical and molecular characterization of the novel BRAF V599Ins mutation detected in a classic papillary thyroid carcinoma 32
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 30
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. 29
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes 28
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. 28
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma 25
Molecular genetics of medullary thyroid carcinoma: The quest for novel therapeutic targets 25
Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas 24
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 23
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 23
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. 18
Totale 1.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.948
article - articoli 5.948
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202411 0 0 0 0 0 0 0 0 2 0 9 0
2024/2025757 8 1 48 20 216 41 10 69 62 27 135 120
2025/2026975 31 86 75 151 188 72 144 38 60 80 29 21
2026/202738 38 0 0 0 0 0 0 0 0 0 0 0
Totale 1.781